235 related articles for article (PubMed ID: 29188193)
1. The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review.
Bento LC; Correia RP; Pitangueiras Mangueira CL; De Souza Barroso R; Rocha FA; Bacal NS; Marti LC
Front Oncol; 2017; 7():270. PubMed ID: 29188193
[TBL] [Abstract][Full Text] [Related]
2. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
3. The role of flow cytometric immunophenotyping in myelodysplastic syndromes.
Pagnucco G; Giambanco C; Gervasi F
Ann N Y Acad Sci; 2006 Nov; 1089():383-94. PubMed ID: 17261782
[TBL] [Abstract][Full Text] [Related]
4. Update on Myelodysplastic Syndromes Classification and Prognosis.
Gratzinger D; Greenberg PL
Surg Pathol Clin; 2013 Dec; 6(4):693-728. PubMed ID: 26839194
[TBL] [Abstract][Full Text] [Related]
5. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
[TBL] [Abstract][Full Text] [Related]
6. World Health Organization classification of myelodysplastic syndromes.
Czader M; Orazi A
Curr Pharm Des; 2012; 18(22):3149-62. PubMed ID: 22571693
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De-Novo, Particularly Low-Grade Myelodysplastic Syndromes.
Gardikas N; Vikentiou M; Konsta E; Kontos CK; Papageorgiou SG; Spathis A; Bazani E; Bouchla A; Kapsimali V; Psarra K; Foukas P; Dimitriadis G; Pappa V
Cytometry B Clin Cytom; 2019 Jan; 96(1):73-82. PubMed ID: 30334347
[TBL] [Abstract][Full Text] [Related]
8. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
[TBL] [Abstract][Full Text] [Related]
9. Role of flow cytometry in diagnostics of myelodysplastic syndromes--beyond the WHO 2008 classification.
Porwit A
Semin Diagn Pathol; 2011 Nov; 28(4):273-82. PubMed ID: 22195405
[TBL] [Abstract][Full Text] [Related]
10. Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment.
Burbury KL; Westerman DA
Leuk Lymphoma; 2014 Apr; 55(4):749-60. PubMed ID: 23808833
[TBL] [Abstract][Full Text] [Related]
11. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
Lu D; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
Aanei CM; Picot T; Tavernier E; Guyotat D; Campos Catafal L
Front Oncol; 2016; 6():161. PubMed ID: 27446807
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndromes/neoplasms: recent classification system based on World Health Organization Classification of Tumors - International Agency for Research on Cancer for Hematopoietic and Lymphoid Tissues.
Gupta G; Singh R; Kotasthane DS; Kotasthane VD
J Blood Med; 2010; 1():171-82. PubMed ID: 22282696
[TBL] [Abstract][Full Text] [Related]
14. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.
Valent P; Horny HP
Eur J Clin Invest; 2009 Jul; 39(7):548-53. PubMed ID: 19453651
[TBL] [Abstract][Full Text] [Related]
15. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndromes in adults].
Beyne-Rauzy O; Laurent G; Adoue D
Presse Med; 2007 Mar; 36(3 Pt 2):481-91. PubMed ID: 17336857
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndromes.
Zhou J; Orazi A; Czader MB
Semin Diagn Pathol; 2011 Nov; 28(4):258-72. PubMed ID: 22195404
[TBL] [Abstract][Full Text] [Related]
18. Diagnostics and Prognostication of Myelodysplastic Syndromes.
Zini G
Ann Lab Med; 2017 Nov; 37(6):465-474. PubMed ID: 28840983
[TBL] [Abstract][Full Text] [Related]
19. The current approach to the diagnosis of myelodysplastic syndromes
Weinberg OK; Hasserjian RP
Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
Della Porta MG; Picone C
Mediterr J Hematol Infect Dis; 2017; 9(1):e2017017. PubMed ID: 28293405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]